Solaris Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Solaris Asset Management's PFE Position: Q1 2018 in Review
Solaris Asset Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 16,374 shares — an estimated $563K sold.
Solaris Asset Management first reported a position in PFE in Q2 2013 and held it in 18 quarters. The position peaked at $1.73M in Q4 2014. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.
- Solaris Asset Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
- Solaris Asset Management sold 16,374 Pfizer shares in Q1 2018, an estimated $563K.
- Solaris Asset Management first reported a position in Pfizer in Q2 2013 and held it in 18 quarters.
- Solaris Asset Management's Pfizer position peaked at $1.73M in Q4 2014.
- 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.
Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.